NovoMatrixTM – the next generation soft-tissue augmentation material

When choosing a biomaterial, there is a strong demand in clinical practice for predictable outcomes. For over 20 years, LifeCellTM, an Allergan affiliate and leading global medical technology company,has developed innovative products for use in a wide range of applications.BioHorizons Camlog expands its soft-tissue portfolio in partnership with LifeCellTMto bringNovoMatrixTM, the next generation of soft-tissue augmentation material, into the European market. Full market release of this product will take place at the Oral Reconstruction Foundation Symposium in New York City in April 2020. What is NovoMatrixTM?NovoMatrixTM is an acellular extracellular dermal matrix consisting of tissue-engineered porcine material.NovoMatrixTMis a breakthrough in xenogenic processing ensuring a structurally intact, undamaged scaffold that supports cell and microvascular ingrowth. The proprietary tissue processing allows for rapid revascularization, cell repopulation and minimal inflammation.NovoMatrixTM comespre-hydrated and ready to use and offers a true alternative to autogenous soft-tissue grafts and current products on the market.Indications and clinical evidenceThe NovoMatrixTM indicationsinclude guided tissue regeneration procedures in recession defects for root coverage, localized gingival augmentation to increase keratinized tissue (KT) around teeth and alveolar ridge reconstruction for prosthetic treatment. Dr Edward Pat Allen, one of the pioneer users ofNovoMatrixTM, says:“Novo...
Source: Dental Technology Blog - Category: Dentistry Source Type: news